Please login to the form below

Not currently logged in
Email:
Password:

Tocagen

This page shows the latest Tocagen news and features for those working in and with pharma, biotech and healthcare.

FDA grants Tocagen’s glioblastoma drug orphan status

FDA grants Tocagen’s glioblastoma drug orphan status

Harry Gruber, CEO of Tocagen, said: “There's an extraordinary need for new treatment options for patients with this devastating disease. ... This programme will be supported by companion diagnostic tests that Tocagen is working on in partnership with

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics